Overactive Bladder: Clinical Trials

1 trial for Overactive Bladder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1

Follow Overactive Bladder: new trials by email Literature Review of Overactive Bladder trials Research Report on Overactive Bladder

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder
Transvaginal botulinum toxin A (BTA) injection - Overactive Bladder, Bladder, Overactive
Early Phase 1CompletedStanford University152019-06-202022-07-19

Narrower conditions

Urinary Bladder, Overactive (1)  ·  Urinary Incontinence, Urge (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Male Urogenital Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Urinary Bladder Diseases (1)  ·  Urinary Incontinence (1)  ·  Urination Disorders (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)  ·  Urological Manifestations (1)

Interventions

Injections (1)

Sponsors

Stanford University (1)

Countries

United States (1)

Top investigators

Amy D. Dobberfuhl, M.D. (1)

Results publications

PMID 34156506, PMID 35607890